Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06915012 · ClinicalTrials.gov registry record · NA
Impact of Biophoton Therapy on Chronic Severe Arthritis Pain
A NA study of Arthritis, sponsored by First Institute of All Medicines.
- Recruiting
- Registry status
- NA
- Development phase
- 102
- Enrollment target
- 1
- Study location
NCT06915012 is a NA study of Arthritis that is actively recruiting participants, run by First Institute of All Medicines. The registered enrollment target is 102 participants, below the 4,508-participant average among 48 other Arthritis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06915012, a NA study of Arthritis, is actively recruiting participants, sponsored by First Institute of All Medicines.
- RECRUITING
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
Study Objective The purpose of this clinical study is to evaluate if biophoton therapy, delivered by Tesla BioHealing® Biophoton Generators (Biophotonizer), can alleviate chronic severe pain. Study Design This is a randomized, double-blinded, placebo-controlled intervention clinical study to assess the effectiveness of biophoton therapy in managing chronic severe pain. Approximately 102 patients with chronic severe arthritis pain will participate in the study. Study Randomization The biostatistician will prepare a randomization schedule including a series of subject numbers. A subject number will be randomly assigned to each study participant, which will assign them to either the control group or the treatment group. Other than the Informed Consent Form (ICF), all study information will be recorded by using the subject number. The Principal Investigator, study physicians, study nurse, data-entry specialists, and biostatisticians, as well as the participants (and caregivers), will be blinded about who received which product during the first two weeks of study participation. Study Enrollment Each potentially qualified patient will review the Informed Consent Form online (e-ICF) and Enrollment Criteria online (e-Criteria) first, then discuss the e-ICF and e-Criteria with the study team medical professional via telephone during the scheduled time. Each qualified patient will sign the e-ICF and send it to the Study Coordinator. The Study Coordinator will assign the qualified patient a randomized subject number, then the patient will become a study participant. Study Procedure We expect that the participant will stay in this clinical treatment for 12 weeks, or 12 weeks if the participants are randomly placed in a placebo group. The 12 weeks of participation are double-blinded to record the placebo effects, as each set of the study device is labelled with a unique code for use by only one participant. The change of the placebo device to the treatment device will be pe
Conditions Studied
Interventions
- DEVICE Tesla BioHealing(R) Biophoton Generators
Study Locations (1)
Pennsylvania
- Tesla BioHealing Medical Center in Butler-PA - Butler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2025-03-28 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06915012
The ClinicalTrials.gov registry entry for NCT06915012 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,508-participant average among 48 other Arthritis trials with a reported enrollment target (98% lower). The listed sponsor is First Institute of All Medicines, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Tesla BioHealing(R) Biophoton Generators is the first listed.
NCT06915012 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06915012 about?
NCT06915012 is a clinical study titled "Impact of Biophoton Therapy on Chronic Severe Arthritis Pain". Study Objective The purpose of this clinical study is to evaluate if biophoton therapy, delivered by Tesla BioHealing® Biophoton Generators (Biophotonizer), can alleviate chronic severe pain. Study Design This is a randomized, double-blinded, placebo-controlled intervention clinical study to assess...
What is the current status of trial NCT06915012?
This trial is currently recruiting. It is a NA study. The enrollment target is 102 participants. The study started on 2025-03-28. Estimated completion is 2026-03-31.
What conditions does trial NCT06915012 study?
This clinical trial studies the following conditions: Arthritis.
What interventions are being tested in trial NCT06915012?
The interventions under investigation include: Tesla BioHealing(R) Biophoton Generators (DEVICE).
Who is sponsoring clinical trial NCT06915012?
This trial is sponsored by First Institute of All Medicines, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06915012 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Expanding Exercise Programming for Veterans Through Telehealth
RECRUITING · NA
-
Dose Response of Exercise for Arthritis Management
RECRUITING · NA
-
Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders.
RECRUITING · NA
-
Geniculate Artery Embolization for Osteoarthritis
RECRUITING · NA
-
Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis
ACTIVE NOT RECRUITING · NA
-
Impact of Different Exercise Programs on Knee OA
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.